We Are….
Innovative
Dogon Behavioral Medical Group, Inc. is leading the way in mental health care in Riverside and surrounding communities. We have brought innovative new treatment to the Inland Empire, and we stay up to date on best practices and the latest advancements in the treatment of mental health.
Expert
Our medical director, Samuel E. Dey, M.D., offers the following qualifications:
25+ years of experience in psychiatry
Board-certified in psychiatry, with added qualifications in geriatric psychiatry
Graduate of Loma Linda University School of Medicine
Caring
We genuinely care about helping our patients, and we feel gratified when we see their quality of life improve. We have helped countless patients feel better and improve their lives, and we’re here to listen to you and help you with whatever might be bothering you.
Convenient & Private
Our location, in a quiet neighborhood just off the 91 Freeway near Riverside Plaza, is convenient and yet private at the same time.
Comprehensive
We offer comprehensive psychiatric treatment, as well as counseling for couples, families and individuals. We have an experienced staff of psychiatrists, psychologists, Licensed Clinical Social Workers and Marriage & Family Therapists.
We offer solutions for adults, seniors, teens and adolescents including:
Alzheimer’s Disease
Anger Management
Anxiety Disorders
Assaultive Behavior
ADHD
Bipolar Disorders
Dementia
Depression
Learning Disorders
Mood Disorders
Personality Disorders
Psychotic Disorders
Relationship Problems
Schizophrenia
What to Expect During Your Visit
What’s the Difference Between a Psychotherapist and a Psychiatrist?
No one will be denied access to services due to an inability to pay. A discounted / sliding fee schedule is available based on family size and income.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.